| |
|
|
|
Catabasis Pharmaceuticals- Inc.  
|
|
0.8658 -0.004 (-0%) |
06-21 10:09 |
|
Open: |
0.8861 |
Pre close: |
0.87 |
Target:
|
1.65
|
|
High: |
0.92 |
Low: |
0.8611 |
Resistance:
|
1.42
1.76
|
|
Volume: |
613,332 |
Market Cap: |
25M |
Support:
|
0.86
0.72
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.04
 |
MACD |
MACD(12,26):
|
-0.18 |
|
MA(20): |
1.43 |
Signal(12,26,9): |
-0.11 |
|
MA(100): |
1.65 |
Stochastic Oscillator |
%K(14,3):
|
2.33 |
|
MA(250): |
1.65 |
%D(3): |
3.74 |
|
Average Volume(K) |
3-Month: |
43277
|
52-Week |
High:
|
3.78 |
|
10-Days: |
162172 |
Low: |
0.86 |
|
RSI |
RSI(14):
|
16.42  |
Change(%): |
-34.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.160 |
Return on Equity (ttm) |
-133.5 |
Shares Out. (M) |
29.04 |
|
EPS Est. Current Year |
-1.390 |
Return on Assets (ttm) |
-95.3 |
Shares Float (M) |
28.53 |
|
EPS Est. Next Year |
-1.100 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.330 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
22.70 |
|
Forward EPS |
-1.190 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
624 |
|
Book Value (p.s.) |
3.100 |
EBITDA (p.s.) |
-0.469 |
P/E |
-0.77 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.29 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-25.55 |
P/S |
1290973184.00 |
|
Operating Margin |
-5394.40 |
Levered Free Cash Flow
(M) |
-15.36 |
P/CF |
-1.01 |
|
|
|
|
|
|
